Secor Capital Advisors’s Boston Scientific BSX Stock Holding History

Secor Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-67,182	Closed	-$1.6M	–	505
2016 Q3	$1.6M	Buy	+67,182	New	+$1.6M	0.17%	178
2015 Q1	–	Sell	-11,814	Closed	-$157K	–	454
2014 Q4	$157K	Buy	+11,814	New	+$151K	0.07%	359
2014 Q3	–	Sell	-82,631	Closed	-$1.05M	–	322
2014 Q2	$1.05M	Buy	+82,631	New	+$1.07M	0.56%	51

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Secor Capital Advisors's BSX Position: Q4 2016 in Review

Secor Capital Advisors sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 67,182 shares — an estimated $1.6M sold.

Secor Capital Advisors first reported a position in BSX in Q2 2014 and held it in 3 quarters. The position peaked at $1.6M in Q3 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

Secor Capital Advisors reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
Secor Capital Advisors sold 67,182 Boston Scientific shares in Q4 2016, an estimated $1.6M.
Secor Capital Advisors first reported a position in Boston Scientific in Q2 2014 and held it in 3 quarters.
Secor Capital Advisors's Boston Scientific position peaked at $1.6M in Q3 2016.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Secor Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.